Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
WaveTec Vision
company
About
WaveTec Vision develops and provides a wavefront measurement technology for cataract surgeons with their ORA System.
- 51 - 100
Highlights
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $15.90M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 1997
- Number Of Employee
- 51 - 100
- Operating Status
- Active
WaveTec Vision is a small company with a big idea – and the ability and the team to achieve it. Their proprietary intraoperative aberrometer system ORange will transform and advance the emerging convergence of refractive and cataract surgery. It was founded in 1997 and headquartered in Aliso Viejo, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$49M
WaveTec Vision has raised a total of
$49M
in funding over 2 rounds. Their latest funding was raised on
May 12, 2011 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 12, 2011 | Series D | $15.90M | 1 |
Versant Ventures
|
— | Detail |
| Feb 1, 2009 | Series C | $20.10M | 1 |
Versant Ventures
|
— | Detail |
| May 31, 2007 | Series B | $13M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
2
1
WaveTec Vision is funded by 1 investors.
Versant Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Versant Ventures
|
Yes | Series D |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
